ACOU085 yakapihwa kumurwere wekutanga ane zera rekurasikirwa kwekunzwa (presbycusis) muChikamu 1b chekiriniki yekudzidza muGermany. Iko kusati kwaongororwa kwevarwere kunoenderana neyakadzama mukati / yekusabvisa maitiro ekuyedzwa kuri kuitika kwave kuda kupera. Pamusoro pechinangwa chechidzidzo, kuyedza kuchengetedzwa uye kushivirira kwemumiriri wemushonga muvanhu kekutanga, ruzhinji rwekuzvimiririra uye bvunzo dzekunzwa dziri kuitwa kutsigira kuferefetwa kwechinangwa.
ACOU085 ndeye proprietary diki-morekuru, otoprotective drug candidate inogadzirisa yakanyatsotsanangurwa molecular target inonyatsoratidzwa mumasero ekunzwa emukati kwenzeve, anonzi masero ebvudzi rekunze (OHC). ACOU085 inoratidzirwa neyakasiyana mbiri maitiro ekuita: iyo morekuru inokonzeresa kukwidziridzwa kwekuita kwekunzwa uye inopa kuchengetedzwa kwenguva refu kweiyo inofa yakasiyaniswa maOHC. Muna Zvita 2021, Acousia Therapeutics yakapihwa CTA neGerman BfArM kuti itange yayo yekutanga-mu-munhu Phase 1b yekiriniki yekuyedza yeACU085.
"Iyi nhanho inotevera yeAcousia's otoprotective drug candidate ACOU085 muzvidzidzo zvevarwere vanotambura ne presbycusis inoratidza chiitiko chakakosha panzira yedu yekuita kurasikirwa kwekunzwa chirwere chinorapika," anodaro Dr. Tim Boelke, Chief Executive Officer uye Chief Medical Officer wekambani.
"Ndinodada zvikuru kuti basa redu rekufungidzira, resainzi rave kupinda muchipatara makore 6 chete mushure mekutanga chirongwa chakazara chekuvandudza zvinodhaka cheNovo parinoveli, rakanangana nemishonga," anowedzera Hubert Löwenheim, Muzvinafundo. Sachigaro weDhipatimendi reOtolaryngology-Musoro & Neck Surgery yeYunivhesiti yeTübingen uye Acousia Therapeutics co-muvambi.
ZVOKUBVA MUNYAYA INO:
- Pamusoro pechinangwa chechidzidzo, kuyedza kuchengetedzeka uye kushivirira kwemumiriri wezvinodhaka muvanhu kekutanga, ruzhinji rwekuzvimiririra uye bvunzo dzekunzwa dziri kuitwa kutsigira kuferefetwa kwechinangwa.
- ACOU085 ndeye proprietary diki-morekuru, otoprotective drug candidate inogadzirisa yakanyatsotsanangurwa molecular target inonyatsoratidzwa mumasero ekunzwa emukati kwenzeve, anonzi masero ebvudzi rekunze (OHC).
- "Ini ndinodada zvikuru kuti basa redu rekufungidzira, resainzi rave kupinda mukiriniki makore matanhatu chete mushure mekutanga chirongwa chakazara che de novo chekuvandudza zvinodhaka pane inoveli, ine hunyanzvi hwezvinodhaka zvinodhaka,".
